696615-07-3

Basic information

• Product Name: (-)-(1R,2R,4S,6R)-1,2-cyclohexylidenedioxy-4-(tert-butyldiphenylsilyloxy)-6-(n-hexyloxy)cyclohexane
• Synonyms: (-)-(1R,2R,4S,6R)-1,2-cyclohexylidenedioxy-4-(tert-butyldiphenylsilyloxy)-6-(n-hexyloxy)cyclohexane
• CAS NO: 696615-07-3
• Molecular Weight: 550.854
• Mol File: 696615-07-3.mol

Chemical Properties

• CAS DataBase Reference: (-)-(1R,2R,4S,6R)-1,2-cyclohexylidenedioxy-4-(tert-butyldiphenylsilyloxy)-6-(n-hexyloxy)cyclohexane(CAS DataBase Reference)
• NIST Chemistry Reference: (-)-(1R,2R,4S,6R)-1,2-cyclohexylidenedioxy-4-(tert-butyldiphenylsilyloxy)-6-(n-hexyloxy)cyclohexane(696615-07-3)
• EPA Substance Registry System: (-)-(1R,2R,4S,6R)-1,2-cyclohexylidenedioxy-4-(tert-butyldiphenylsilyloxy)-6-(n-hexyloxy)cyclohexane(696615-07-3)

Safety Data

• Hazardous Substances Data: 696615-07-3(Hazardous Substances Data)

Upstream product

• 638-45-9 1-Iodohexane 
• 186703-33-3 (-)-(1S,2R,4S,6R)-1,2-cyclohexyldienedioxy-4-(tert-butyldiphenylsilyloxy)cyclohexan-6-ol 

Relevant articles and documents

Removal of the phosphate group in mechanism-based inhibitors of inositol monophosphatase leads to unusual inhibitory activity.

Inositol monophosphatase is widely held to be the therapeutic target for inhibition by lithium ion in the treatment of bipolar disorder. In a continued effort to improve the bioavailability of alternative inhibitors, we have designed and tested two new se